Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
2023 · BMC Cancer · 8 citations
https://doi.org/10.1186/s12885-023-10687-8
K
Ke Jiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
678
Citations
12
h-index
14
i10-index
Ke Jiang is an academic researcher from Nantong University. The author has contributed to research in topics: Advanced Battery Materials and Technologies & Advancements in Battery Materials & Membrane Separation Technologies. The author has an h-index of 12, co-authored 27 publications.
ORCID: 0000-0002-8077-5951Papers by this author
worksEfficacy, safety, and prognostic modeling in neoadjuvant immunotherapy for esophageal squamous cell carcinoma
2024 · International Immunopharmacology · 6 citations
https://doi.org/10.1016/j.intimp.2024.112845
Lithium ion-regulated monomer reactive sites heighten selectivity of polyamide nanofiltration membranes
2025 · Journal of Membrane Science · 1 citations
https://doi.org/10.1016/j.memsci.2025.124729
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat